PLRX
#4125
Pliant Therapeutics, Inc. - Common Stock
1.1 1 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.48%
Monthly Change
+4.72%
6 month change
-12.60%
Year Change
-31.06%
Previous Close
1.1 5
Open
1.1 1
Low
1.1 1
High
1.1 1
Volume
14
Financials
- Market Capitalization 68.73 M
- Employee 49
- Founded 2015
- CEO N/A
- Website www.pliantrx.com
- Headquarter Delaware, United States
- FIGI BBG00C8083N4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.5
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4115 |  MNOV MediciNova, Inc. - Common Stock | 1.44 USD | +1.41% | +3.60% | +9.09% | +10.77% | 70.88 M USD | ||
| 4122 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.20 USD | -0.83% | -1.64% | 0.00% | -41.18% | 69.88 M USD | ||
| 4127 |  XBIT XBiotech Inc. - Common Stock | 2.27 USD | -1.30% | -0.44% | +0.89% | -27.94% | 69.21 M USD | ||
| 4133 |  CSBR Champions Oncology, Inc. - Common Stock | 4.93 USD | -1.79% | -2.76% | -6.10% | -25.98% | 68.50 M USD |
Frequently asked questions about Pliant Therapeutics, Inc. Common Stock
What is the Pliant Therapeutics, Inc. Common Stock stock price today?
The current price of Pliant Therapeutics, Inc. Common Stock (PLRX) is 1.11. Over the past 24 hours, the stock has changed by -3.48%. Follow the PLRX chart for real-time price dynamics.
What is the stock ticker of Pliant Therapeutics, Inc. Common Stock?
Pliant Therapeutics, Inc. Common Stock trades under the ticker PLRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pliant Therapeutics, Inc. Common Stock stock going up?
PLRX has changed by -2.63% over the last week, +4.72% over the last month, and -31.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Pliant Therapeutics, Inc. Common Stock?
Pliant Therapeutics, Inc. Common Stock currently has a market capitalization of 68.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Pliant Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Pliant Therapeutics, Inc. Common Stock reported earnings of -0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Pliant Therapeutics, Inc. Common Stock revenue for the last quarter?
Pliant Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Pliant Therapeutics, Inc. Common Stock net income for the last quarter?
Pliant Therapeutics, Inc. Common Stock reported net income of -22.37 M for the last quarter. The previous quarter showed -20.04 M, which means net income changed by -11.63%.
Is Pliant Therapeutics, Inc. Common Stock a good dividend stock?
Pliant Therapeutics, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Pliant Therapeutics, Inc. Common Stock have?
As of the latest available data, Pliant Therapeutics, Inc. Common Stock has 49 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Pliant Therapeutics, Inc. Common Stock stock?
You can buy Pliant Therapeutics, Inc. Common Stock (PLRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pliant Therapeutics, Inc. Common Stock stock?
Investing in Pliant Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLRX chart and related analysis on metatrader.com as part of your research.